LGALS3BP and viral pneumonia: With the aid of the discovered biomarkers, we concluded that HYQ has a specific effect on viral pneumonia such as elevated galectin-3-binding protein (Lgals3bp) and glutathione peroxidase 3 (Gpx3) levels in blood.